{
  "id": 16073090,
  "title": "Scientists Use AI-Designed Viruses to Treat Human Patient",
  "url": "https://urgent.news/2026/10/22/scientists-use-ai-designed-viruses-to-treat-human-patient",
  "topic": "ai",
  "section": "AI",
  "published": "2026-10-22T15:51:34.000Z",
  "source": {
    "name": "ProPakistani",
    "slug": "propakistani",
    "url": "https://propakistani.pk/2026/10/22/scientists-use-ai-designed-viruses-to-treat-human-patient/"
  },
  "original_language": "en",
  "account": "For the first time ever, scientists have administered an AI-designed virus to a human patient in an experimental treatment for a serious bacterial infection, according to The New York Times. The treatment employs bacteriophages, or phages, which are viruses that infect and kill bacteria. The researchers aim to use AI-generated phages to eradicate an E. coli infection that has eluded antibiotics and conventional phage therapies.\n\nUS biotech firm Radical Numerics developed the treatment using its AI model, Omnii, which can dissect DNA sequences, protein structures, and other biological data. The company engineered a modified version of the T7 virus, specifically targeting E. coli bacteria. Researchers employed Omnii to redesign the virus's leg-like structures, enabling it to attach to bacterial strains that previous phages couldn't infect. After generating the new viral genomes, scientists produced the corresponding DNA and inserted it into bacteria. Laboratory tests revealed that the modified viruses could infect and kill the targeted bacteria. Prior to administering the treatment, the researchers conducted safety assessments before delivering the viruses to the patient's treating physicians.\n\nThe US Food and Drug Administration (FDA) authorized the experimental treatment; however, Radical Numerics has not disclosed the patient's identity or the medical professionals involved, citing confidentiality requirements. The company's clinical findings have not been peer-reviewed or published in a scientific journal.\n\nThis development builds upon previous AI research conducted at the Arc Institute in California, where in 2025, researchers employed an AI model named Evo 2 to generate approximately 700,000 viral genomes. From the generated designs, 285 were selected for laboratory testing, resulting in the identification of 16 viable viruses. Three of the project's researchers, including Dr. Eric Nguyen, later founded Radical Numerics. In June 2026, the company unveiled Omnii, an AI system capable of handling various biological data types. Beyond virus design, Radical Numerics is investigating potential applications in cancer vaccine development and identifying possible pandemic risks.\n\nRadical Numerics believes AI could drastically reduce the time required to create personalized treatments for antibiotic-resistant infections. Traditional phage therapy often involves extensive searches for viruses capable of attacking specific bacterial strains. By utilizing AI to design suitable viruses, researchers anticipate shortening the process to just a few days. Eric Nguyen, the company's chief executive, expressed optimism that the team could eventually create personalized treatments within days. Nevertheless, additional clinical evidence is necessary to determine whether AI-designed phages can safely and effectively treat human infections. The treatment marks an early clinical application of AI-designed viruses, but its efficacy has yet to be confirmed.",
  "summary": "Scientists have administered artificial intelligence-designed viruses to a human patient for the first time in an experimental treatment aimed at … Read More The post Scientists Use AI-Designed Viruses to Treat Human Patient appeared first on ProPakistani .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}